Update on the efficacy and tolerability of meropenem in the treatment of serious bacterial infections

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
John F Mohr

Abstract

Meropenem is a carbapenem antibiotic approved by the US Food and Drug Administration for the treatment of complicated skin and skin-structure infections, complicated intra-abdominal infections, and pediatric bacterial meningitis (in patients >or=3 months of age). In clinical trials, it also has shown efficacy as initial empirical therapy for the treatment of nosocomial pneumonia. Unlike other beta-lactam antibiotics, including third-generation cephalosporins, carbapenems have shown activity against extended-spectrum beta-lactamase-producing and AmpC chromosomal beta-lactamase-producing bacteria. Compared with imipenem, meropenem is more active against gram-negative pathogens and somewhat less active against gram-positive pathogens, and it does not require coadministration of a renal dehydropeptidase inhibitor. In most comparative trials, clinical and bacteriological response rates with imipenem and meropenem were similar. Compared with clindamycin/tobramycin, meropenem is associated with a reduced length of hospital stay and a shorter duration of therapy among patients with complicated intra-abdominal infections. Meropenem is well tolerated by children and adults and has an acceptable safety profile. Alternative meropenem dosin...Continue Reading

References

Jan 1, 1995·The Journal of Antimicrobial Chemotherapy·B BrismarT Skau
Jun 1, 1993·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K KanellakopoulouP Sfikakis
Jul 1, 1995·The Journal of Antimicrobial Chemotherapy·Y J Mouton, C Beuscart
Jul 1, 1995·The Journal of Antimicrobial Chemotherapy·W K HuizingaS J Karran
Feb 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S E Wilson
Feb 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A Arrieta
Feb 3, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J GarauJ Rello
Apr 8, 1998·Current Opinion in Pediatrics·I R Friedland, I Lutsar
May 21, 1998·Antimicrobial Agents and Chemotherapy·C A JaspersI M Hoepelman
Apr 30, 1999·International Journal of Antimicrobial Agents·J S BradleyJ P Quinn
Apr 30, 1999·Mayo Clinic Proceedings·W C Hellinger, N S Brewer
Jun 1, 1999·The Journal of Antimicrobial Chemotherapy·F ThalhammerH Burgmann
Mar 30, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·S R Norrby
Feb 13, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C Verwaest, UNKNOWN Belgian Multicenter Study Group
Feb 24, 2001·The Medical Clinics of North America·B A Cunha
Mar 10, 2001·Journal of Chemotherapy·F Alvarez Lerma, UNKNOWN Serious Infection Study Group
Mar 10, 2001·Indian Journal of Pediatrics·N KöksalS Celebi
Aug 17, 2001·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·S S SantosA A Barone
Sep 26, 2003·Therapeutic Drug Monitoring·Kassa AyalewBarbara A Jantausch
Oct 3, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph S SolomkinUNKNOWN Infectious Diseases Society of America
Jul 20, 2004·Drugs·Murugan Raghavan, Peter K Linden
Jul 21, 2004·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Srividya KotapatiJoseph L Kuti
Aug 31, 2004·Journal of Chemotherapy·S J BermanUNKNOWN Merrem Hospital-Acquired Pneumonia Study Group
Feb 9, 2005·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society, UNKNOWN Infectious Diseases Society of America
Oct 6, 2005·Surgical Infections·Jose M Tellado, Samuel E Wilson
Sep 22, 2006·Journal of Clinical Pharmacology·Chonghua LiDavid P Nicolau
May 10, 2007·Drugs·George G ZhanelJames A Karlowsky
Aug 19, 2007·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Peter Linden
Oct 18, 2007·JAMA : the Journal of the American Medical Association·R Monina KlevensUNKNOWN Active Bacterial Core surveillance (ABCs) MRSA Investigators
Dec 8, 2007·American Journal of Infection Control·William R JarvisMarguerite Jackson

❮ Previous
Next ❯

Citations

Feb 4, 2010·Journal of Medicinal Chemistry·Peter OelschlaegerJeffrey H Toney
May 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas TängdénJan Sjölin
Jun 14, 2013·Chemistry Central Journal·Judyta Cielecka-PiontekPiotr Garbacki
Dec 21, 2013·Enfermedades infecciosas y microbiología clínica·Elena Montesinos-SanchisConcepción Figueras-Nadal
Nov 26, 2010·Otolaryngologic Clinics of North America·Marilyn E Levi, Vincent D Eusterman
Dec 25, 2015·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Imraan JoosubAbdul Salam
Jun 26, 2009·Journal of Clinical Pharmacology·Iolanda CirilloRebecca Redman
Mar 11, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John E MazuskiJan Pachl
Jul 23, 2013·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Lorenzo ZaffiriLuis H Toledo-Pereyra
Jun 28, 2016·International Journal of Antimicrobial Agents·Kritsana KongthavonsakulPeninnah Oberdorfer
Oct 8, 2016·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Joseph S Van TuylPeter N Johnson
Mar 8, 2011·The Pediatric Infectious Disease Journal·Nicolas DaubyMarie-Christine Payen
Jan 18, 2017·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·Alferso C AbrahamsWalther H Boer
May 8, 2020·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Yoshiro SakaiHiroshi Watanabe
Mar 30, 2012·The Journal of Antimicrobial Chemotherapy·R Nalda-MolinaG Valsami
Sep 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marin H Kollef
Dec 21, 2018·BMJ Case Reports·Timothy TattersallAndrew Redmond
Jan 15, 2021·Antibiotics·Santiago Garnica-VelandiaCarlos Arturo Alvarez-Moreno
Dec 7, 2010·Enfermedades infecciosas y microbiología clínica·María José Fresnadillo MartínezJosé Elías García Sánchez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Bacterial Meningitis

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Bacterial Meningitis (ASM)

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.